Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Add filters

Document Type
Year range
Annals of medicine and surgery (2012) ; 81:104421-104421, 2022.
Article in English | EuropePMC | ID: covidwho-1999199


The COVID-19 pandemic brought to the surface the dwindling state of mental health services in Africa. While most countries have policies targeted at mental health problems, these policies are often weak and outdated to combat the present challenges. Africa faces various challenges in mental health delivery, ranging from inadequate staffing to sociocultural stigma and lack of effort from the government in terms of policies and funding. Many countries do not have the budgetary allocation for mental health. while those with budgetary allocation spend less than 5% of government health expenditure on mental health. Considering the continent's socioeconomic difficulties, it is almost a given that mental health illnesses will be on the rise. The continent's growing population, which is majorly youth, means that mental health services will be in high demand in the coming years. Therefore, the relevant stakeholders must look into the challenges and respond with a sense of urgency.

Ann Med Surg (Lond) ; 81: 104377, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-1982538


Since the initial identification of the Marburg virus in 1967, it has sporadically emerged in several countries throughout Africa, including Zimbabwe, Kenya, South Africa, the Democratic Republic of the Congo (DRC), Uganda, and Zimbabwe. Due to the concurrent occurrence of other epidemics like the coronavirus disease 2019 (COVID-19), this outbreak could endanger the healthcare systems in these many African nations. Recently, two cases of the Marburg virus were detected in Ghana for the first time. However, there has been a noticeable lack of information concerning this recent outbreak of July 2022 in Ghana. Therefore, this article seeks to provide an overview of this outbreak in Ghana to better understand the most recent status and current efforts being made to mitigate the dissemination of the Marburg virus. We also suggest recommendations that may contribute to limiting the burden of this virus.

Ann Med Surg (Lond) ; 80: 104197, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1926187


The Coronavirus Disease - 19 (COVID-19) pandemic has put additional strain on Africa's fragile healthcare systems and has impacted the rise of emerging and re-emerging infectious diseases. Currently, there is a rise in cases of Monkeypox Disease, a zoonotic viral disease caused by the Monkeypox virus, which was first documented in 1970 in the Democratic Republic of the Congo. Most of the clinical symptoms of Monkeypox resemble that of smallpox, whose virus also belongs to the same genus. Initial symptoms include headache, fever, and fatigue, followed by lymphadenopathy and a rash. This study aims to provide more insight into Monkeypox by exposing its current burden and efforts to combat it amidst COVID-19 in Africa. Since Monkeypox disease is re-emerging and is less contagious than COVID-19, prevention and treatment are much more manageable. Still, African countries face several crucial challenges in responding to the Monkeypox in times of the covid-19 pandemic. These include lack of a well-functioning surveillance system for early detection of the disease, lack of awareness and knowledge of the monkeypox disease across the general population, lack of healthcare facilities already burdened by COVID-19 cases, and shortage of trained healthcare professionals. On the other hand, one significant factor contributing to the minimized risk in Africa was the smallpox vaccination done before 1980. However, a declining cross-protective immunity is seen in those inoculated with the smallpox vaccine and the ever-increasing risk to the unvaccinated population. Thus, focusing on vaccination and disease surveillance operations and diligent monitoring, as well as cross-border collaborations with international sectors, including One Health, FOA, OIE, and WHO is critical to achieving the ultimate eradication of monkeypox in Africa.

Afr J Emerg Med ; 12(2): 117-120, 2022 Jun.
Article in English | MEDLINE | ID: covidwho-1706220


Since the beginning of the COVID-19 pandemic, millions have suffered globally and as a result, attention and resources for other diseases, such as Crimean-Congo Haemorrhagic Fever (CCHF), has declined. Despite a significantly lower incidence rate compared to COVID-19, CCHF has a considerably higher mortality rate at approximately 30%. Both diseases share symptoms such as headache, fever, nausea and vomiting, fatigue, sore throat, however they have different modes of transmission, mortality rates, and incubation periods. Public health professionals have faced several challenges when attempting to prevent and control the spread of both diseases and despite their differences, many of the prevention methods remain the same. These include increasing public awareness regarding avoiding contact with infected individuals and animals, training healthcare professionals in emergency and preparedness for disease outbreaks and increasing the investment in medical supplies and treatment to control the spread of both diseases.